Live from the NIH registry
Studies recruiting near Ann Arbor right now
Top 25 of 1,174 recruiting studies, sorted by proximity — each links to its official registry page
Nephrotic Syndrome Study Network
Minimal Change Disease (MCD), Membranous Nephropathy
N/A
Observational 1,200 participants sought
CS Mott Children's Hospital, University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: University of Michigan
One-Time DNA Study for Vasculitis
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis
N/A
Observational 1,000 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: University of Pennsylvania
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Michigan Heart — Ypsilanti, Michigan (6.5 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Mechanisms of Fatigability With Diabetes
Pre-diabetes, Type 2 Diabetes
N/A
Interventional 80 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: University of Michigan
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Syndax Pharmaceuticals
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2
Interventional 120 participants sought
C.S. Mott Children's Hospital — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Nationwide Children's Hospital
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
University of Michigan Medical School — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
C S Mott Children's Hospital — Ann Arbor, Michigan (0.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Thrombocythemia, Essential, Primary Myelofibrosis
Phase 3
Interventional 400 participants sought
University of Michigan ( Site 6000) — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
Rheumatoid Arthritis, Interstitial Lung Disease
N/A
Observational 450 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: University of Colorado, Denver
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Detroit Clinical Research Center — Farmington Hills, Michigan (23.1 mi)
· Sponsor: Regeneron Pharmaceuticals
Designing and Assessing a Women Only Cardiac Rehabilitation (CARE) Program
Cardiac Rehabilitation, Cardiovascular Diseases
N/A
Interventional 60 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: University of Michigan
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Kura Oncology, Inc.
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
Neuroblastoma Recurrent
Phase 2
Interventional 54 participants sought
Motts Childrens Hospital — Ann Arbor, Michigan (0.5 mi)
· Sponsor: St. Jude Children's Research Hospital
A Study of the TheraBionic P1 Device in Breast Cancer
Breast Cancer Stage I, Breast Cancer Stage II
N/A
Interventional 24 participants sought
Karmanos Cancer Institute Weisberg Cancer Treatment Center — Farmington Hills, Michigan (23.1 mi)
· Sponsor: Barbara Ann Karmanos Cancer Institute
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
Amyotrophic Lateral Sclerosis, Neuromuscular Disease
N/A
Interventional 2 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Paradromics
Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation
Parkinson Disease
N/A
Observational 15 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: University of Michigan
Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance
Obesity
N/A
Observational 3,200 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: University of Michigan
Cephea Early Feasibility Study
Mitral Regurgitation
N/A
Interventional 90 participants sought
University of Michigan - Davis Medical Center — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Abbott Medical Devices
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
A Retrospective Study to Characterize Participants With Propionic Acidemia
Propionic Acidemia
N/A
Observational 60 participants sought
University of Michigan Hospital — Ann Arbor, Michigan (0.5 mi)
· Sponsor: ModernaTX, Inc.
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc
Prostate Cancer
Phase 2
Interventional 60 participants sought
VA Ann Arbor Healthcare System, Ann Arbor, MI — Ann Arbor, Michigan (0.5 mi)
· Sponsor: VA Office of Research and Development
Adversity, Brain and Opioid Use Study
Opioid Use Disorder, Healthy
N/A
Interventional 185 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: University of Michigan
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer Site in Ann Arbor, MI — Ann Arbor, Michigan (0.5 mi)
· Sponsor: Mediar Therapeutics
Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024
Lipodystrophy, Partial
Phase 2
Interventional 32 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi)
· Sponsor: University of Michigan